Is drug delivery the enemy of drug research?
By Albedo
Article
Pharmaceutical Technology Europe
Pharmaceutical Technology EuropePharmaceutical Technology Europe-01-01-2003
Volume 15
Issue 1
Brussels report
The European drug industry's dilemma gets no easier - drugs must be discovered before they can be delivered. However, the pharmaceutical sector's reluctance to pay for delivery still threatens to deprive the industry of the revenue to do its research.
This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europesubscribe here now.
Articles in this issue
Taking the Industry's Pulse: Fifth Annual International Employment Survey
Taking the Industry's Pulse: Fifth Annual International Employment Survey
Is drug delivery the enemy of drug research?
Improving Dose Content Uniformity Testing for MDIs and DPIs
Innovations in Pharmaceutical Packaging - Smart Blister Packs
Pharmaceutical Pricing and Innovation: Key Issues in the Year Ahead
PS 9100:2002 Pharmaceutical Excipients - An Updated GMP Standard for Excipients Suppliers
Recent Videos
Related Content
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Article
Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
